CBP and ICE Chiefs Faced Off Against Unhinged Dems...and One Said the Quiet...
Democrat Presidential Hopeful Has Been Telling Some Weird Lies About His Ancestor and...
DOJ Charges Two Men in $120 Million Adult Day Care Fraud Scheme
The Press Gets Unwound by Their Solitary Sources, and the NYT Goes Winter...
Chewing the Fat on the Left's 'Body Positivity' Flip Flop
National Nurses Union Calls for the Abolition of ICE
Delaware Smacked Down for Trying to Enforce Law, Ignoring Injunction
The Clintons Are So Over
Tensions Rise At the White House's New Religious Liberty Commission as One Member...
Mike Johnson Blasts Mamdani's DOH for Creating a ‘Global Oppression’ Group Focused on...
Kentucky Senate Candidate Andy Barr Endorses Pro-Amnesty Book Despite Pledging to Be ‘Amer...
The NYT Report on the Marijuana Epidemic Is a Startling Warning
Democrat Attacks Christians, Calls Muslim Jihad on the West a 'Middle Eastern Version...
Even CNN Knows That Democrats Are on the Wrong Side of the Voter...
Ken Paxton Notches Immigration Win As Premier Community for Illegals Pays Out $68...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos